Cell surface expression of LDL receptor in chronic hepatitis C: Correlation with viral load

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 1, 2007, Pages

  Petit, Jean Michel ^a,b,d   Minello, Anne ^a   Duvillard, Laurence ^a   Jooste, Valérie ^a   Monier, Serge ^a   Texier, Véronique ^b   Bour, Jean Baptiste ^c   Poussier, Alix ^b   Gambert, Philippe ^a   Verges, Bruno ^a,b   Hillon, Patrick ^a  

^a INSERM   (France)

^b Services de Diabétologie et Endocrinologie   (France)

^c Laboratoire de Virologie   (France)

^d HÔPITAL DU BOCAGE   (France)

Author keywords

Cytometry; Fibrosis; Lipoproteins

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBROSIS; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VIRUS LOAD;

ADULT; AGED; ANTIGENS, SURFACE; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, LDL; VIRAL LOAD; VIRUS REPLICATION;

EID: 34547101446     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00091.2007     Document Type: Article

References (26)

1. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low-density lipoprotein receptor. Proc Natl Acad Sci USA 96: 12766-12771, 1999.
2. Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, Pol S, Brechot C, Paranhos-Baccala G, Lotteau V. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76: 6919-6928, 2002.
3. André P, Perlemuter G, Budkowska A, Bréchot C, Lotteau V. Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 25: 93-104, 2005.
4. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudoparticles containing functional E1-E2 envelope protein complexes. J Exp Med 197: 633-642, 2003.
5. Bradley D, McCaustland K, Krawczynski K, Spelbring J, Humphrey C, Cook EH. Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J Med Virol 34: 206-208, 1991.
6. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47, 1986.
7. Diedrich G. How does hepatitis C virus enter cells? FEBS J 273: 3871-3885, 2006.
8. Enjoji M, Nakamuta M, Kinukawa N, Sugimoto R, Noguchi K, Tsuruta S, Iwao M, Kotoh K, Iwamoto H, Nawata H. Beta-lipoproteins influence the serum level of hepatitis C virus. Med Sci Monit 6: 841-844, 2000.
9. Favre D, Muellhaupt B. Potential cellular receptors involved in hepatitis C virus entry into cells 4:9. Lipids Health Dis 4: 9, 2005.
10. Gopal K, Johnson TC, Gopal S, Walfish A, Bang CT, Suwandhi P, Pena-Sahdala HN, Clain DJ, Bodenheimer HC Jr, Min AD. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment. Hepatology 44: 335-340, 2006.
11. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67: 1952-1958, 1993.
12. Ikeda M, Abe K, Yamada M, Dansako H, Naka K, Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44: 117-125, 2006.
13. Lonardo A, Loria P, Bertolotti M, Carulli N. Statins and HCV: A complex issue. Hepatology 45: 257, 2007.
14. Molina S, Castet V, Fournier-Wirth C, Pichard-Garcia L, Avner R, Harats D, Roitelman J, Barbaras R, Graber P, Ghersa P, Smolarsky M, Funaro A, Malavasi F, Larrey D, Coste J, Fabre JM, Sa-Cunha A, Maurel P. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 46: 411-419, 2007.
15. Monazahian M, Bohme I, Bonk S, Koch A, Scholz C, Grethe S, Thomssen R. Low-density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57: 223-229, 1999.
16. Mustad VA, Etherton TD, Cooper AD, Mastro AM, Pearson TA, Jonnalagadda SS, Kris-Etherton PM. Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. J Lipid Res 38: 459-468, 1997.
17. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chretien Y, Koike K, Pessayre D, Chapman J, Barba G, Brechot C. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low-density lipoprotein secretion: a model of viral-related steatosis. FASEB J 16: 185-194, 2002.
18. Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P. HCV-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis and liver fibrosis. Am J Gastroenterol 98: 1150-1154, 2003.
19. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 282: 938-941, 1998.
20. Powel EE, Kroon PA. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. J Clin Invest 93: 2168-2174, 1994.
21. Price DA, Bassendine MF, Norris SM, Golding C, Toms GL, Schmid ML, Morris CM, Burt AD, Donaldson PT. Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut 55: 715-718, 2006.
22. Roach PD, Kerry NL, Whiting MJ, Nestel PJ. Coordinate changes in the low density lipoprotein receptor activity of liver and monuclear cells in the rabbit. Atherosclerosis 101: 157-164, 1993.
23. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21: 5017-5025, 2002.
24. Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 34: 428-434, 2001.
25. Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of B-lipoproteins and immunoglobulins. Med Microbiol Immunol (Berl) 182: 329-334, 1993.
26. Wunschmann S, Medh JD, Klinzmann D, Schmidt WN, Stapleton JT. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 74: 10055-10062, 2000.